UC AKT.ANL. 03/25 FRE/ DE000HD44XR8 /
1/10/2025 9:00:50 AM | Chg.-0.270 | Bid9:20:24 AM | Ask9:20:24 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.550EUR | -0.27% | 101.810 Bid Size: 500,000 |
101.870 Ask Size: 500,000 |
FRESENIUS SE+CO.KGAA... | 24.00 - | 3/28/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil